| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/22/2001 | EP1124940A1 A system for preparing of a culture medium for bacteriological use |
| 08/22/2001 | EP1124855A2 Compositions and methods for treating polycystic kidney disease |
| 08/22/2001 | EP1124852A1 Lysine-rich statherin protein |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124849A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
| 08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 08/22/2001 | EP1124844A1 G protein-coupled receptor resembling the thrombin receptor |
| 08/22/2001 | EP1124843A1 Low allergenic protein variants |
| 08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
| 08/22/2001 | EP1124835A1 Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection |
| 08/22/2001 | EP1124813A1 Microbial transformation product |
| 08/22/2001 | EP1124630A1 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating |
| 08/22/2001 | EP1124560A1 Use of antifungal agents for treating scleroses |
| 08/22/2001 | EP0930929B1 Microbiological method for eliminating halogenated ethenes |
| 08/22/2001 | EP0795022B1 Municipal solid waste processing facility and commercial lactic acid production process |
| 08/22/2001 | EP0764204B1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 08/22/2001 | EP0725794B1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 08/22/2001 | EP0550645B1 Surface expression libraries of heteromeric receptors |
| 08/22/2001 | CN1309721A Heteroduplex mutational vectors and use thereof in bacteria |
| 08/22/2001 | CN1309720A Virulence-associated nucleic acid sequences and uses thereof |
| 08/22/2001 | CN1309718A Improved microbial strains producing sphingoid bases |
| 08/22/2001 | CN1309717A Cell-free chimeraplasty and fukaryotic use of heteroduplex mutational vector |
| 08/22/2001 | CN1309712A Method of making proteins in transformed yeast cells |
| 08/22/2001 | CN1309711A Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal nutant cells |
| 08/22/2001 | CN1309709A Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/22/2001 | CN1309708A Postweaning multisystemic wasting syndrome virus from pigs |
| 08/22/2001 | CN1309707A BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 08/22/2001 | CN1309706A Compound from moraxella catarrhalis |
| 08/22/2001 | CN1309703A Mutants of mycobacterium species and use of same for screening for antibiotics vectors |
| 08/22/2001 | CN1309702A Glutaminase, gene thereof and process for producing same |
| 08/22/2001 | CN1309700A Glucoamylase variants |
| 08/22/2001 | CN1309697A Method for enhancing catalytic activity of cells |
| 08/22/2001 | CN1309664A Anti hepatitis C virus antibody and uses thereof |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/22/2001 | CN1309566A Nocathiacin antibiotics |
| 08/22/2001 | CN1309184A Operation of enzymatic vitality of protoporphyrin primary oxidase in eukaryote |
| 08/22/2001 | CN1309178A Full-synthetic culture medium and its application |
| 08/22/2001 | CN1309177A Se-enriched high-biomass yeast and its preparing process |
| 08/22/2001 | CN1309176A Separated strain of Antrodia camphorate, process for preparing its culture medium and its product |
| 08/22/2001 | CN1309175A Process for preparing three-fungus symbiote and health-care liquid prepared from it |
| 08/22/2001 | CN1069895C Legionella specific antibiotic, microorganism producing antibiotic and process for producing same |
| 08/22/2001 | CN1069821C Iodine-enriched spirulina powder and its use |
| 08/21/2001 | USRE37336 Method for providing hyaluronic acid |
| 08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
| 08/21/2001 | US6277978 KVLQT1—a long QT syndrome gene |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277975 Fusions of P-selectin ligand protein and polynucleotides encoding same |
| 08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/21/2001 | US6277970 PRP-like gene |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277963 Antibodies directed toward extracellular signal-related kinases |
| 08/21/2001 | US6277959 Isolated mammalian membrane protein genes; related reagents |
| 08/21/2001 | US6277822 Family of peptides known as xenoxins |
| 08/21/2001 | US6277648 Process and a device for the isolation of cell components such as nucleic acids from natural sources |
| 08/21/2001 | US6277634 Hybridized with target rna to be cleaved; medical diagnosis or gene therapy, drugs |
| 08/21/2001 | US6277631 Recombinant yeast (schizosaccharomyces pombe or saccharomyces cerevisiae) expression vectors |
| 08/21/2001 | US6277625 For control of diseases caused by the soil-borne fungus, rhizoctonia and diseases caused by gaeumannomyces graminis or pythium |
| 08/21/2001 | US6277623 Vector for use as tool in genetic engineering |
| 08/21/2001 | US6277621 Artificial chromosome constructs containing foreign nucleic acid sequences |
| 08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
| 08/21/2001 | US6277619 Enzymatic polypeptide associated with generating glucose; for the diagnosis, treatment, and prevention of disorders of metabolism and cancer |
| 08/21/2001 | US6277616 Endo-fucoidan-lyase |
| 08/21/2001 | US6277615 (1→3, 1→4)—β-glucanase of enhanced stability |
| 08/21/2001 | US6277614 Enzymatic protein associated with recombination; for use as tool in genetic engineering and gene therapy |
| 08/21/2001 | US6277612 Polypeptides having galactose oxidase activity and nucleic acids encoding same |
| 08/21/2001 | US6277608 Cloning target nucleotide sequences; mixing expression vector and target nucleotide sequences, incubate with recombinase, amplify and recover target sequences |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277598 Nucleotide sequences associated with the activation of immunocompetent cells; for the reduction of side effects associated with cancer treatment; for amplifying cytotoxicity of killing cells; for the treatment viral diseases |
| 08/21/2001 | US6277594 Neurogenesis inducing gene |
| 08/21/2001 | US6277593 Generating preferential polypeptide; culture transformed cells, express preferential polypeptide, recover preferential polypeptide |
| 08/21/2001 | US6277592 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 08/21/2001 | US6277590 Genetically engineered aggregates for generating preferential heterologous proteins |
| 08/21/2001 | US6277586 Used for detecting the presence of autoantibodies to glutamic acid decarboxylaes (gad) in a biological sample |
| 08/21/2001 | US6277585 Vertebrate unc-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins; use in diagnosis, therapy and in the biopharmaceutical industry |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277568 Nucleic acids encoding human ubiquitin-conjugating enzyme homologs |
| 08/21/2001 | US6277564 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 08/21/2001 | US6277374 Process for producing by culturing Lactobacillus casei var. rhamnosus yeast and mold inhibiting products |
| 08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 08/21/2001 | CA2334041A1 Enzyme with xylanase activity |
| 08/21/2001 | CA2090969C Production of insulin-like growth factor-1 in methylotrophic yeast cells |
| 08/21/2001 | CA2059167C Expression of human serum albumin in pichia pastoris |
| 08/21/2001 | CA2012955C Antitumor substance be-13793c |
| 08/17/2001 | CA2334072A1 Method for determining the effects of a growth-altering agent on a microbial colony |
| 08/16/2001 | WO2001059450A2 Cells expressing zinc finger protein for drug discovery |
| 08/16/2001 | WO2001059145A1 Regulated expression of plac in staphylococcus aureus |
| 08/16/2001 | WO2001059140A1 Transgenic cells expressing glucosyltransferase nucleic acids |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059126A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | WO2001059123A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059115A2 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059112A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/16/2001 | WO2001059110A2 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059107A1 Novel scavenger receptors |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |